Wednesday, July 12, 2017 8:39:21 AM
On April 28, 2017, a third-party lender with various amounts outstanding agreed to release and waive a
total of $367,170, inclusive of accrued interest thereon, with no further consideration payable.
On June 15, 2017, a total of 3,000,000 shares originally issued to settle part of convertible note in the
amount of $3,000 as discussed in Note 9(c)above were returned to
treasury and canceled.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM